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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S233Th2, Th17, Treg) and activation markers. T-cell cytokine secretion (IL-2, IL-
4, IL-6, IL-10, IL-17A, INF-g, TNF) in SF was measured by cytometric bead
array (CBA) analysis.
Results: Analysis of PB did not show any signiﬁcant difference within the
OA patient groups and in comparison to controls. In SM a distinct inﬁl-
tration of CD4+ T-cells was present in all three OA groups, which signiﬁ-
cantly increasedwith OA stage (p<0.05). Further, CD4+ T-cell subsets in SM
and PB samples were analysed. Whereas in PB only a small proportion of
CD4+ T-cells were activated and stained positive for the speciﬁc subsets,
the majority of SM T-cells were differentiated into the T-cell subsets and
this increasedwith OA stage (Figure 1). The highest increase wasmeasured
for the inﬂammatory T cell subsets Th1 and Th17, which signiﬁcantly
altered the Th1/Th2 and Th17/Treg balance. Further analysis of activation
markers displayed an activated phenotype of CD4+ T-cells in the SM
(CD69+, CD45RO+, CD45RA-, CD62L-) but not in PB. CBA analysis
conﬁrmed a signiﬁcant increase of all T-cell cytokines in the SF of OA
groups 2 and 3 when compared to group 1 (p<0.05). Between group 2 and
3, pro-inﬂammatory Th1 and Th17 cytokines (TNF and IL-17) were further
increased and anti-inﬂammatory Th2 and Treg cytokines (IL-4, IL-10)
decreased in group 3. IL-2, IL-6 and INF-g were slightly higher in group 2.
Conclusions: In contrast to SM, no differences were observed between the
PB samples of OA patients and controls, showing that the relevant role of
inﬂammatory cells in OA remains a local process. The inﬁltration of OA
synoviumwith inﬂammatory cells is not solely a phenomenon of late stage
OA. In fact, CD4+ T-cells are already present and activated in the affected
joints of early OA stages. T-cell inﬁltration and polarisation correlates with
OA disease stages and shifts the Th1/Th2 and Th17/Treg balance towards
an inﬂammatory T-cell phenotype. Thus, onset and progression of OA is
accompanied by an increasing inﬂux of CD4+ T-cells into the SM, their
activation, cytokine production and polarisation. These results underline
the relevance of T-cells in the inﬂammatory process of OA, not only in late-
stage disease but also in early OA stages. In “classical” inﬂammatory joint
diseases such as rheumatoid arthritis we know that T-cell derived
inﬂammation contributes to cartilage degeneration and joint destruction.
The role of these cells in OA needs to be further studied. Nevertheless our
current results suggest that T-cell activation and polarisation may play
a role in both the initiation and progression of OA, and as such provide
a potential therapeutic target.
Ă
457
OSTEOARTHRITIS-ASSOCIATED BASIC CALCIUM PHOSPHATE CRYSTALS
INDUCE IL-1b, IL-18 AND S100A8 PRODUCTION IN A TYROSINE
KINASE DEPENDENT MANNER.
E. Mills 1, G. McCarthy 2, K. Mills 1, A. Dunne 1. 1 Trinity Coll. Dublin, Dublin,
Ireland; 2Mater Misericordiae Univ. Hosp., Dublin, Ireland
Purpose: Synovial ﬂuid basic calcium phosphate (BCP) crystal deposition
is a marker of severe joint degeneration in osteoarthritis (OA). BCP crystals
are found in the majority of OA joints, where they promote pro-inﬂam-
matory cytokine production and matrix metalloprotease (MMP)expression, suggesting a pathogenic role for these crystals in driving
disease progression. At the molecular level, BCP crystals were shown to
activate synovial ﬁbroblasts and macrophages through a variety of sig-
nalling pathways, including protein kinase C (PKC), ERK1/2, MAP kinase
and NFkB, leading to the induction of cytokines such as TNFa and IL-6.
More recently it has been demonstrated that BCP crystals drive IL-1b and
IL-18 production following activation of the NOD-like receptor, NLRP3. This
event requires two signals, the ﬁrst leading to the production of pro-IL-1b/
18 and the second leading to inﬂammasome complex assembly and
cleavage of the immature cytokines to their biologically active forms. In
this study we sought 1) to determinewhether cell membrane activation by
BCP crystals leads in turn to the activation of the membrane proximal
kinases, Syk and PI3 kinase and 2) to further characterise events down-
stream of Syk activation in order to identify novel molecular targets for the
treatment of BCP related arthropathies.
Methods: Murine dendritic cells and macrophages were stimulated with
BCP crystals, with or without priming with a Toll-like receptor (TLR)
agonist and IL-1b and IL-18 production was quantiﬁed by enzyme linked
immunosorbent assay (ELISA). A role for Syk and PI3 kinase was deter-
mined with the use of the inhibitors, piceatannol and LY294002, respec-
tively. Activation of the kinases was conﬁrmed by western blotting using
phospho-speciﬁc antibodies to Syk and PI3 kinase following treatment of
cells with the crystals over a 30 minute time course. Finally, activation of
the downstream kinase, ERK, and production of the damage associated
molecule, S100A8, was assessed in the presence of piceatannol in order to
determine if these events are associated with BCP dependent Syk
activation.
Results: Physiological concentrations of BCP crystals (50mg/ml) induced
robust IL-1b and IL-18 production in a Syk and PI3 kinase dependent
manner. Activation of the kinases was apparent after approximately
5 minutes treatment with the crystals while pre-incubation with the
inhibitors piceatannol and Ly294002 led to a signiﬁcant reduction in
cytokine levels (>80%). Phosphorylation of the downstream kinase, ERK,
was also prevented following treatment with the Syk inhibitor, picea-
tannol, thus identifying Syk activation as a proximal event in BCP induced
pro-inﬂammatory cytokine production. Finally, we demonstrate that
treatment of cells with BCP crystals leads directly to the induction and
release of the danger-associated molecule, S100A8 and this is also
dependent on activation of Syk.
Conclusions: Based on these studies we propose that membrane acti-
vation by BCP crystals leads directly to the activation of Syk and its
interacting partner, PI3 kinase. Inhibition of these kinases signiﬁcantly
abrogates both IL-1 and IL-18 production as well as activation of the
downstream kinase, ERK. We have also demonstrated that production of
the damage associated molecule, S100A8 is dependent on Syk activation.
Given that S100A8 is considered a TLR 4 ligand, we propose a model
whereby BCP crystals drive the production of S100A8 which in turn leads
to the expression of pro-IL-1b and pro-IL-18 (Signal 1). In dendritic cells/
macrophages, BCP crystals can also induce the activation of the NLRP3
inﬂammasome (Signal 2) leading to the production of the mature forms
of these cytokines. These events are dependent on tyrosine phosphory-
lation and we identify Syk and molecules activated downstream of
this kinase as a potential targets for the treatment of BCP related path-
ologies.
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ALARMINS S100A8 AND S100A9 STIMULATE PRODUCTION OF PRO-
INFLAMMATORY CYTOKINES IN M2 MACROPHAGES WITHOUT
CHANGING THEIR M2 MEMBRANE PHENOTYPE
R.F. Schelbergen 1, A.B. Blom1, W. de Munter 1, T. Vogl 2, J. Roth 2, W.B. van
den Berg 1, P.L. van Lent 1. 1Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
Netherlands; 2 Inst. of Immunology, Munster, Germany
Purpose: Synovial activation, which plays an important role in a subgroup
of osteoarthritis (OA) patients, is regulated by M1/M2 macrophage
subpopulations: pro-inﬂammatory M1-macrophages and regulatory M2-
macrophages. Alarmins S100A8 and S100A9 are found in high concen-
trations in synovial ﬂuid of OA patients and are correlated to inﬂammation
and cartilage destruction. In the current study we investigated the
production of S100A8 and/or S100A9 by M1- and M2-macrophages and
